Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Perspective on the CD47-SIRPA Axis in High-Risk Neuroblastoma

1 Jun 2024

Abstract excerpt

Neuroblastoma is a pediatric cancer with significant clinical heterogeneity. Despite extensive efforts, it is still difficult to cure children with high-risk neuroblastoma. Immunotherapy is a promising approach to treat children with this devastating disease. We have previously reported that macrophages are important effector cells in high-risk neuroblastoma. In this perspective article, we discuss the potential...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Erythrocyte Function and Pathophysiology
Share to Neuroblastoma Research and Treatments
Share to Phagocytosis and Immune Regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38920727
DOI: 10.3390/curroncol31060243

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Perspective on the CD47-SIRPA Axis in High-Risk NeuroblastomaPMID 38920727Read ↗

Recent Advances of Tumor Therapy Based on the CD47-SIRPα AxisSemantic proximity Read ↗

Advances in Anti-Tumor Treatments Targeting the CD47/SIRPα AxisSemantic proximity Read ↗

Blockade of CD47 or SIRPα: a new cancer immunotherapySemantic proximity Read ↗

The CD47-SIRP signalling system: its physiological roles and therapeutic applicationSemantic proximity Read ↗

Macrophage-mediated anti-tumor immunity against high-risk neuroblastomaSemantic proximity Read ↗

"Re-educating" Tumor Associated Macrophages as a Novel Immunotherapy Strategy for Neuroblastoma.Semantic proximity Read ↗

The Interaction Between Signal Regulatory Protein Alpha (SIRPα) and CD47: Structure, Function, and Therapeutic TargetSemantic proximity Read ↗

Phagocytosis Checkpoints in Glioblastoma: CD47 and BeyondSemantic proximity Read ↗

SIRPα controls CD47-dependent platelet clearance in mice and humansSemantic proximity Read ↗

Isoform switching of CD47 induces macrophage-initiated cancer cell pyroptosisSemantic proximity Read ↗

DSP107 combines inhibition of CD47/SIRPα axis with activation of 4-1BB to trigger anticancer immunitySemantic proximity Read ↗

Replication Study: The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumorsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.